Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumor × Re-Irradiation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Glioblastoma 5 Recurrence 4 Head and Neck Neoplasms 3 Diffuse Intrinsic Pontine Glioma 3 Glioma 2 Brain Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Recurrence of Head and Cancer in Irraiated Area 1 Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Diseases 1 Nasopharyngeal Carcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Brain Stem Neoplasms 1

Interventions

pembrolizumab 12 Injections 12 Paclitaxel 10 Docetaxel 9 Cisplatin 8 senaparib 7 Nivolumab 7 Capecitabine 7 Bevacizumab 7 toripalimab 6 atezolizumab 6 Irinotecan 6 Cyclophosphamide 6 tislelizumab 5 Fluorouracil 5 fludarabine 4 apatinib 4 Leucovorin 4 Ipilimumab 4 Gemcitabine 4 Fluorodeoxyglucose F18 4 spartalizumab 3 pertuzumab 3 olaparib 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Oxaliplatin 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05301101 2025-06-29

REDIRICT

Medical College of Wisconsin

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡